Concepedia

Theodore M. Kamenecka

TM

Statistics

Publications

131

Citations

11K

H-Index

52

Active since

1991

Affiliations

Scripps Research Institute(Current)

Harvard University

Merck & Co., Inc., Rahway, NJ, USA (United States)

Dana-Farber Cancer Institute

The University of Adelaide

Theodore M. Kamenecka is an author at Scripps Research Institute specializing in pharmacology, life sciences, and ligand binding.

ORCID

Publications per year

1991–2025

131

Publications

131

Anti-diabetic drugs inhibit obesity-linked phosphorylation of PPARγ by Cdk5

Jang Hyun Choi, Alexander S. Banks, Jennifer L. Estall et al. · Nature · 2010 · 881 citations

, , +14

Regulation of circadian behaviour and metabolism by synthetic REV-ERB agonists

Laura A. Solt, Yongjun Wang, Subhashis Banerjee et al. · Nature · 2012 · 826 citations · Full text

, , +14

Antidiabetic actions of a non-agonist PPARγ ligand blocking Cdk5-mediated phosphorylation

Jang Hyun Choi, Alexander S. Banks, Theodore M. Kamenecka et al. · Nature · 2011 · 538 citations · Full text

, , +15

Suppression of TH17 differentiation and autoimmunity by a synthetic ROR ligand

Laura A. Solt, Philippe Nuhant, Yongjun Wang et al. · Nature · 2011 · 505 citations

, , +14

Rev-erb-α modulates skeletal muscle oxidative capacity by regulating mitochondrial biogenesis and autophagy

Estelle Woldt, Yasmine Sebti, Laura A. Solt et al. · Nature Medicine · 2013 · 438 citations · Full text

, , +12

1–5 of 131